|
AU2016238894A1
|
|
Prevention of tissue ischemia, related methods and compositions
|
|
EP3399055A1
|
|
Compositions and methods for detection and discrimination of influenza viruses
|
|
AU2014224073A1
|
|
Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
|
|
AU2014201936A1
|
|
Prevention of tissue ischemia, related methods and compositions
|
|
AU2014200453A1
|
|
Differential gene expression in physiological and pathological angiogenesis
|
|
AU2014200215A1
|
|
Engineered antibody constant domain molecules
|
|
AU2013222027A1
|
|
Micro-RNA-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
|
|
AU2013305744A1
|
|
Engineered anthrax lethal toxin for targeted delivery
|
|
AU2013202127A1
|
|
Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
|
|
AU2013274879A1
|
|
Methods and compositions for detection of Legionella
|
|
AU2012261687A1
|
|
Brachyury polypeptides and methods for use
|
|
EP2773776A1
|
|
Broad detection of dengue virus serotypes
|
|
CA2837731A1
|
|
Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development
|
|
EP3466440A1
|
|
Chimpanzee adenoviral vector-based filovirus vaccines
|
|
EP2498677A2
|
|
System for magnetic resonance spectroscopy of brain tissue for pattern-based diagnostics
|
|
NZ714757A
|
|
Use of il-15 to increase thymic output and to treat lymphopenia
|
|
AU2009212747A1
|
|
Engineered antibody constant domain molecules
|
|
CA2678901A1
|
|
Methods for modulating embryonic stem cell differentiation
|
|
CA2678404A1
|
|
Brachyury polypeptides and methods for use
|
|
AU2008200601A1
|
|
Inhibitor of DNA Methylation
|
